Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 242M | 325M | 277M | 286M |
Cost of revenue | 168M | 224M | 195M | 190M |
Gross profit | 74M | 101M | 82M | 96M |
Operating expense | ||||
Research & development | 19M | 17M | 17M | 18M |
Selling general and admin | 69M | 77M | 69M | 76M |
Other operating expenses | 6M | 67M | 5M | 5M |
Operating income | -8M | -44M | 2M | 7M |
Non operating interest income | ||||
Income | 2M | 3M | 3M | 3M |
Expense | 3M | 4M | 4M | 4M |
Other income expense | — | — | — | — |
Pretax income | -15M | -53M | -5M | 0 |
Tax provision | 6M | 9M | 7M | 0 |
Net income | -20M | -63M | -13M | 5M |
Basic EPS | -0.1 | -0.4 | -0.1 | 0.0 |
Diluted EPS | -0.1 | -0.4 | -0.1 | 0.0 |
Basic average shares | 153.8M | 152.5M | 162.5M | 154.8M |
Diluted average shares | 153.8M | 152.5M | 162.5M | 154.8M |
EBITDA | -2M | -39M | 10M | 15M |
Net income from continuing op. | -22M | -63M | -13M | 4M |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |